House Committee Probes IRS’ Alleged Seizure of Medical Records

A House committee is investigating allegations the Internal Revenue Service improperly seized millions of medical records from a California healthcare provider.

Advertisement

Leaders from the Energy and Commerce Committee sent a letter to IRS Acting Administrator Daniel Werfel requesting information about the seizure. Mr. Werfel assumed his post last month after Commissioner Steven Miller was pushed out amid findings the IRS discriminated against Tea Party groups.

The investigation follows a recent class-action lawsuit filed in federal court by a California lawyer on behalf of an unnamed company. The suit claims the IRS seized the records when executing a warrant related to a former employee’s financial records. Plaintiffs say the alleged seizure violated the Fourth Amendment, which protects against unlawful searches.

“In light of these allegations and in anticipation of the IRS’s increased role in implementing healthcare under the Patient Protection and Affordable Care Act, we are writing to request information regarding your agency’s ability to both protect the confidential medical information of millions of Americans and respect the safeguards imposed by HIPAA,” committee leaders wrote in the letter.

More Articles on Healthcare Investigations:

Updated Fraud Self-Disclosure Protocol: 5 Considerations for Healthcare Providers
10 Recent Investigations, Lawsuits and Settlements Involving Hospitals
Idaho State University to Pay HHS $400K to Settle HIPAA Violations

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.